Literature DB >> 1330299

Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis.

S D Weitman1, A G Weinberg, L R Coney, V R Zurawski, D S Jennings, B A Kamen.   

Abstract

In the past year, gp38, a glycosyl-phosphatidylinositol linked membrane protein that is overexpressed in some malignant tissues, has been shown to be the folate receptor. Using immunohistochemical techniques with the monoclonal antibody MOv19 against gp38, we evaluated the cellular localization of folate receptors in normal human tissues, which are potential target sites for drugs that utilize this uptake mechanism. The choroid plexus was intensely positive with staining limited to the epithelium, which in some foci had a distinct bilaminar pattern limited to the luminal and basal surfaces. The epithelium of the fallopian tube, uterus, and epididymis was highly immunoreactive. The acinar cells of the breast, submandibular salivary, and bronchial glands also showed intense staining as did the trophoblastic cells of the placenta. In the kidney reactivity was localized to the proximal tubules. Lung alveolar lining including type I and II pneumocytes stained intensely. Limited but focal reactivity was noted in the vas deferens, ovary, thyroid, and pancreas. This study in conjunction with previous work showing marked overexpression of folate receptor in some malignant cells suggests that the folate receptor may be an important target for diagnostic or therapeutic exploitation and indicates sites of potential drug toxicity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330299

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  71 in total

1.  High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.

Authors:  Maria Ines Nunez; Carmen Behrens; Denise M Woods; Heather Lin; Milind Suraokar; Humam Kadara; Wayne Hofstetter; Neda Kalhor; J Jack Lee; Wilbur Franklin; David J Stewart; Ignacio I Wistuba
Journal:  J Thorac Oncol       Date:  2012-05       Impact factor: 15.609

2.  The effects of folate-conjugated gold nanorods in combination with plasmonic photothermal therapy on mouth epidermal carcinoma cells.

Authors:  Alireza Mehdizadeh; Sajjad Pandesh; Ali Shakeri-Zadeh; Seyed Kamran Kamrava; Mojtaba Habib-Agahi; Mohammad Farhadi; Morteza Pishghadam; Amirhossein Ahmadi; Sanam Arami; Yuri Fedutik
Journal:  Lasers Med Sci       Date:  2013-09-07       Impact factor: 3.161

3.  Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.

Authors:  Manasa Ravindra; Mike R Wilson; Nian Tong; Carrie O'Connor; Mohammad Karim; Lisa Polin; Adrianne Wallace-Povirk; Kathryn White; Juiwanna Kushner; Zhanjun Hou; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2018-04-27       Impact factor: 7.446

4.  Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; Oscar J Santiesteban; J Manuel Perez
Journal:  J Am Chem Soc       Date:  2011-09-27       Impact factor: 15.419

5.  Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients.

Authors:  Matthew P Goetz; Keith L Knutson; Nadine Norton; Bahaaeldin Youssef; David W Hillman; Aziza Nassar; Xochiquetzal J Geiger; Brian M Necela; Heshan Liu; Kathryn J Ruddy; Mei-Yin C Polley; James N Ingle; Fergus J Couch; Edith A Perez; Minetta C Liu; Jodi M Carter; Roberto A Leon-Ferre; Judy C Boughey; Elizabeth B Somers; Krishna R Kalari; Daniel W Visscher
Journal:  NPJ Breast Cancer       Date:  2020-02-04

Review 6.  Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.

Authors:  Rongbao Zhao; Larry H Matherly; I David Goldman
Journal:  Expert Rev Mol Med       Date:  2009-01-28       Impact factor: 5.600

7.  A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis.

Authors:  Rongbao Zhao; Sang Hee Min; Yanhua Wang; Estela Campanella; Philip S Low; I David Goldman
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

8.  A complementary strategy for enhancement of nanoparticle intracellular uptake.

Authors:  Yingjia Li; Ge Wen; Dongxiao Wang; Xia Zhang; Yaoyong Lu; Jianguo Wang; Lijuan Zhong; Hongbing Cai; Xingmei Zhang; Ying Wang
Journal:  Pharm Res       Date:  2014-02-21       Impact factor: 4.200

9.  Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed.

Authors:  Daniel C Christoph; Bernadette Reyna Asuncion; Biftu Hassan; Cindy Tran; Julia D Maltzman; Daniel J O'Shannessy; Murry W Wynes; Thomas C Gauler; Jeremias Wohlschlaeger; Mathias Hoiczyk; Martin Schuler; Wilfried E Eberhardt; Fred R Hirsch
Journal:  J Thorac Oncol       Date:  2013-01       Impact factor: 15.609

10.  Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.

Authors:  Ian R Corbin; Kenneth K Ng; Lili Ding; Andrea Jurisicova; Gang Zheng
Journal:  Nanomedicine (Lond)       Date:  2012-10-15       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.